This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Pancreatic cancer is one of the dreaded malignancies for both the patient and the clinician.
The five-year survival rate of pancreatic adenocarcinoma (PDA) is as low as 2% despite …

Background Surgery for pancreatic endocrine tumors (PETs) with blood vessel involvement
is controversial. Hypothesis Resection of PETs with major blood vessel involvement can be …

Although distal pancreatectomy with en bloc celiac resection (DP-CAR) is used to treat
locally advanced pancreatic cancer, the advantages and disadvantages of this surgical …

Background Celiac trunk encasement by adenocarcinoma of the pancreatic body is
generally regarded as a contraindication for surgical resection. Recent studies have …

Purpose This study aimed at demonstrating the feasibility of retrospectively fused 18 F FDG-
PET and MRI (PET/MRI fusion image) in diagnosing pancreatic tumor, in particular …

Pancreatic ductal adenocarcinoma (PDA) remains one of the most aggressive tumors with a
low rate of survival. Surgery is the only curative treatment for PDA, although only 20% of …

Simple Summary The literature is conflicting regarding the feasibility and survival outcomes
of distal pancreatectomy with celiac axis resection (DP-CAR), although this procedure, in …

Pancreatic cancer is a dismal disease with an increasing incidence. Despite the majority of
patients are not candidates for curative surgery, a subgroup of patients classified as …

Objectives Vascular invasion (VI) is the most important factor in assessing operability for
pancreatic cancer. The accuracy of preoperative vascular staging with computed …